AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W959. A total of 4 filers reported holding AMICUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $988,000 | -88.5% | 100,000 | -73.2% | 0.00% | -100.0% |
| Q4 2020 | $8,601,000 | +79.7% | 372,500 | +9.6% | 0.00% | 0.0% |
| Q3 2020 | $4,787,000 | +1405.3% | 340,000 | +1511.4% | 0.00% | – |
| Q2 2020 | $318,000 | +63.1% | 21,100 | 0.0% | 0.00% | – |
| Q1 2020 | $195,000 | -50.0% | 21,100 | -47.2% | 0.00% | – |
| Q4 2019 | $390,000 | -18.8% | 40,000 | 0.0% | 0.00% | – |
| Q2 2019 | $480,000 | -11.8% | 40,000 | 0.0% | 0.00% | – |
| Q1 2019 | $544,000 | -53.2% | 40,000 | -58.4% | 0.00% | – |
| Q3 2018 | $1,162,000 | +85.9% | 96,100 | +140.2% | 0.00% | – |
| Q2 2018 | $625,000 | -53.8% | 40,000 | -55.6% | 0.00% | – |
| Q1 2018 | $1,354,000 | -5.9% | 90,000 | -10.0% | 0.00% | – |
| Q4 2017 | $1,439,000 | -28.0% | 100,000 | -26.5% | 0.00% | – |
| Q3 2017 | $1,999,000 | +423.3% | 136,000 | +94.3% | 0.00% | – |
| Q2 2016 | $382,000 | -83.5% | 70,000 | -74.5% | 0.00% | -100.0% |
| Q1 2016 | $2,317,000 | – | 274,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 28,500 | $658,000 | 0.00% |
| JPMORGAN CHASE & CO | 372,500 | $8,601,000 | 0.00% |
| SIMPLEX TRADING, LLC | 233 | $537,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |